Kevin D. Weber - 22 Jul 2025 Form 4 Insider Report for Biofrontera Inc. (BFRI)

Role
Director
Signature
/s/ Daniel Hakansson, Attorney-in-fact for Kevin D. Weber
Issuer symbol
BFRI
Transactions as of
22 Jul 2025
Transactions value $
$0
Form type
4
Filing time
16 Sep 2025, 21:22:42 UTC
Previous filing
16 Jul 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Weber Kevin Daniel Director 120 PRESIDENTIAL WAY, SUITE 330, WOBURN /s/ Daniel Hakansson, Attorney-in-fact for Kevin D. Weber 16 Sep 2025 0001916746

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BFRI Employee stock option (right to buy) Award $0 +20K $0.00 20K 22 Jul 2025 Common Stock 20K $1.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in twelve equal monthly installments beginning on August 22, 2025.
F2 Options with different terms are not included.